[HTML][HTML] Opportunities and challenges for human papillomavirus vaccination in cancer

R Roden, PL Stern - Nature Reviews Cancer, 2018 - nature.com
The discovery of genotype 16 as the prototype oncogenic human papillomavirus (HPV)
initiated a quarter century of laboratory and epidemiological studies that demonstrated their …

[HTML][HTML] L2, the minor capsid protein of papillomavirus

JW Wang, RBS Roden - Virology, 2013 - Elsevier
The capsid protein L2 plays major roles in both papillomavirus assembly and the infectious
process. While L1 forms the majority of the capsid and can self-assemble into empty virus …

The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding

RC Kines, CD Thompson, DR Lowy… - Proceedings of the …, 2009 - National Acad Sciences
Using a murine challenge model, we previously determined that human papillomavirus
(HPV) pseudovirions initially bind preferentially to the cervicovaginal basement membrane …

[HTML][HTML] Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16

XS Chen, RL Garcea, I Goldberg, G Casini… - Molecular cell, 2000 - cell.com
The papillomavirus major late protein, L1, forms the pentameric assembly unit of the viral
shell. Recombinant HPV16 L1 pentamers assemble in vitro into capsid-like structures, and …

Efficient intracellular assembly of papillomaviral vectors

CB Buck, DV Pastrana, DR Lowy, JT Schiller - Journal of virology, 2004 - Am Soc Microbiol
Although the papillomavirus structural proteins, L1 and L2, can spontaneously coassemble
to form virus-like particles, currently available methods for production of L1/L2 particles …

[HTML][HTML] Prophylactic human papillomavirus vaccines

DR Lowy, JT Schiller - The Journal of clinical investigation, 2006 - Am Soc Clin Investig
Human papillomavirus (HPV) infection causes virtually all cases of cervical cancer, the
second most common cause of death from cancer among women worldwide. This Review …

[HTML][HTML] Understanding and learning from the success of prophylactic human papillomavirus vaccines

JT Schiller, DR Lowy - Nature Reviews Microbiology, 2012 - nature.com
An estimated 5% of human cancers are caused by human papillomavirus (HPV) infections,
and most of these cancers are of the cervix. Two prophylactic HPV vaccines that target the …

Arrangement of L2 within the papillomavirus capsid

CB Buck, N Cheng, CD Thompson, DR Lowy… - Journal of …, 2008 - Am Soc Microbiol
Papillomaviruses are a family of nonenveloped DNA tumor viruses. Some sexually
transmitted human papillomavirus (HPV) types, including HPV type 16 (HPV16), cause …

Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine

CD Harro, YYS Pang, RBS Roden… - Journal of the …, 2001 - academic.oup.com
Background: Studies in animal models have shown that systemic immunization with a
papillomavirus virus-like particle (VLP) vaccine composed of L1, a major structural viral …

Human papillomavirus infection: biology, epidemiology, and prevention

ME SCHEURER, G Tortolero-Luna… - International Journal of …, 2005 - ijgc.bmj.com
Over the past several decades, knowledge of the biology and epidemiology of human
papillomavirus (HPV) infection has increased tremendously. However, there are still many …